Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2139028rdf:typepubmed:Citationlld:pubmed
pubmed-article:2139028lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2139028lifeskim:mentionsumls-concept:C0032043lld:lifeskim
pubmed-article:2139028lifeskim:mentionsumls-concept:C0205103lld:lifeskim
pubmed-article:2139028lifeskim:mentionsumls-concept:C0005270lld:lifeskim
pubmed-article:2139028lifeskim:mentionsumls-concept:C0162330lld:lifeskim
pubmed-article:2139028lifeskim:mentionsumls-concept:C1514570lld:lifeskim
pubmed-article:2139028lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2139028pubmed:issue12lld:pubmed
pubmed-article:2139028pubmed:dateCreated1990-5-24lld:pubmed
pubmed-article:2139028pubmed:abstractTextThe lysosomal hydrolase beta-hexosaminidase (beta-N-acetylhexosaminidase, EC 3.2.1.52) exists as two major isozymes in normal human tissue: an acidic A-form and a basic B-form. There are also minor forms of intermediate pI known as I-forms. Increases in one or more of these intermediates have been associated with various disease states. Although the two major isozymes have been extensively studied, the structure and biosynthetic origins of the I-forms are unknown. Characterization of a placental hexosaminidase I-form, presented in this report, demonstrates that it is composed of two forms of partially processed hexosaminidase A. The major form contains an intact pro-alpha chain and a pro-beta chain lacking 2 residues from its amino terminus (Ala and Arg). The minor form also contains an alpha and a beta subunit, but each has undergone further proteolytic processing. The amino terminus of each of these partially processed polypeptide chains matches one of those previously found on stable processing intermediates in a single normal human fibroblast cell line. These data confirm that similar processing intermediates exist in human placenta, suggesting that this I-form lacks a unique enzymatic function in vivo. A sequence of normal proteolytic processing events is postulated.lld:pubmed
pubmed-article:2139028pubmed:languageenglld:pubmed
pubmed-article:2139028pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139028pubmed:citationSubsetIMlld:pubmed
pubmed-article:2139028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2139028pubmed:statusMEDLINElld:pubmed
pubmed-article:2139028pubmed:monthAprlld:pubmed
pubmed-article:2139028pubmed:issn0021-9258lld:pubmed
pubmed-article:2139028pubmed:authorpubmed-author:MahuranD JDJlld:pubmed
pubmed-article:2139028pubmed:issnTypePrintlld:pubmed
pubmed-article:2139028pubmed:day25lld:pubmed
pubmed-article:2139028pubmed:volume265lld:pubmed
pubmed-article:2139028pubmed:ownerNLMlld:pubmed
pubmed-article:2139028pubmed:authorsCompleteYlld:pubmed
pubmed-article:2139028pubmed:pagination6794-9lld:pubmed
pubmed-article:2139028pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:meshHeadingpubmed-meshheading:2139028-...lld:pubmed
pubmed-article:2139028pubmed:year1990lld:pubmed
pubmed-article:2139028pubmed:articleTitleCharacterization of human placental beta-hexosaminidase I2. Proteolytic processing intermediates of hexosaminidase A.lld:pubmed
pubmed-article:2139028pubmed:affiliationResearch Institute, Hospital for Sick Children, Toronto, Ontario, Canada.lld:pubmed
pubmed-article:2139028pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2139028pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3074entrezgene:pubmedpubmed-article:2139028lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2139028lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2139028lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2139028lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2139028lld:pubmed